Fox Chase Cancer Center News

PHILADELPHIA (March 13, 2024) — Anthony Villano, MD, Assistant Professor in the Department of Surgical Oncology at Fox Chase Cancer Center, and Joceline Vu, MD, Assistant Professor of Surgery at the Lewis Katz School of Medicine at Temple University, were recently elected members of the Education Committee of the Association for Academic Surgery (AAS).

PHILADELPHIA (March 8, 2024) — Sanjay S. Reddy, MD, FACS, an Associate Professor in the Department of Surgical Oncology at Fox Chase Cancer Center, was recently chosen as a participant in the Society of Surgical Oncology’s (SSO) inaugural Career Catalyst Mentorship Program.

PHILADELPHIA (March 1, 2024) — Fox Chase Cancer Center’s Cancer Epigenetics Institute will hold its fourth annual free hybrid Cancer Epigenetics Symposium at the Franklin Institute in Philadelphia on Thursday, March 7. The annual event brings research leaders together to explore the latest discoveries that will assist in bringing epigenetics from the lab to patients.

PHILADELPHIA (February 29, 2024) — While sociodemographic, clinical, and pathological factors may affect racial and ethnic disparities in outcomes of patients with locally advanced rectal cancer, non-Hispanic Black patients consistently saw less favorable treatment outcomes independent of those factors, according to a study from researchers at Fox Chase Cancer Center published today.

PHILADELPHIA (February 28, 2024) – With 65 guests and infinite kindness, members of the Nursing Professional Development Council and the Department of Nursing of Fox Chase Cancer Center hosted “That’s Amore!,” on Tuesday, February 13. This Valentine-themed dinner featured a host of Italian delights and brought together cancer patients and their families staying at Hope Lodge.

PHILADELPHIA (February 23, 2024) — Prior research has shown that delays in initiating cancer therapy are increasing, and these delays can lead to not only worse outcomes for patients, but also increased psychological distress. However, a new study published by researchers at Fox Chase Cancer Center has found that patients’ worry and fear can also contribute to their intentionally delaying the start of treatment.

PHILADELPHIA (February 22, 2024) — TFE3-rearranged renal cell carcinoma (rRCC) is a rare subtype of kidney cancer that can be misdiagnosed. This can affect treatment decisions and lead to patients receiving the wrong type of treatment. Now, a recently published study by scientists at Fox Chase Cancer Center identifies key genetic markers that can be used to distinguish rRCC from other cancers and also confirms which therapies are likely to be most effective. 

PHILADELPHIA (February 22, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Joyce G. Habib, MD, as an Assistant Professor in the breast medical oncology program in the Department of Hematology/Oncology.